Effect of mifepristone (25 mg) in treatment of uterine myoma in perimenopausal woman.

about

A randomized control trial to assess efficacy of Mifepristone in medical management of uterine fibroid.Mifepristone Therapy in Symptomatic Leiomyomata Using a Variable Dose Pattern with a Favourable Outcome.

P2860

Q51829625-C32E84A6-9C06-4371-96CA-29449E416740 Q55405976-FC31885B-8CA9-44B0-A439-3F730E28C866

P2860

Effect of mifepristone (25 mg) in treatment of uterine myoma in perimenopausal woman.

Item

http://www.wikidata.org/entity/Q36984302

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Effect of mifepristone (25 mg) in treatment of uterine myoma in perimenopausal woman.

@en

type

Item

label

Effect of mifepristone (25 mg) in treatment of uterine myoma in perimenopausal woman.

@en

prefLabel

Effect of mifepristone (25 mg) in treatment of uterine myoma in perimenopausal woman.

@en

P1476

Effect of mifepristone (25 mg) in treatment of uterine myoma in perimenopausal woman.

@en

P2093

A S Mathur

http://www.w3.org/2001/XMLSchema#string

Ekta Singh

http://www.w3.org/2001/XMLSchema#string

Garima Gupta

http://www.w3.org/2001/XMLSchema#string

Neeru Goel

http://www.w3.org/2001/XMLSchema#string

Shikha Seth

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic review of mifepristone for the treatment of uterine leiomyomata.

The estimated annual cost of uterine leiomyomata in the United States.

Innovative oral treatments of uterine leiomyoma

Mifepristone 2.5 mg versus 5 mg daily in the treatment of leiomyoma before surgery.

Mifepristone for treatment of uterine leiomyoma. A prospective randomized placebo controlled trial.

Low-dose mifepristone in treatment of uterine leiomyoma: a randomised double-blind placebo-controlled clinical trial.

Transvaginal ultrasound studies of vascular and morphological changes in uteri exposed to diethylstilbestrol in utero.

Long-term mifepristone (RU486) therapy resulting in massive benign endometrial hyperplasia.

Regression of uterine leiomyomata to the antiprogesterone RU486: dose-response effect.

Clinical efficacy of the antiprogesterone RU486 in the treatment of endometriosis and uterine fibroids.

P304

22-26

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/0976-7800.109630

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23833529

http://www.w3.org/2001/XMLSchema#string

P932

3702060

http://www.w3.org/2001/XMLSchema#string

Effect of mifepristone (25 mg) in treatment of uterine myoma in perimenopausal woman.

about

P2860

P2860

Effect of mifepristone (25 mg) in treatment of uterine myoma in perimenopausal woman.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932